Jaguar Animal Health (JAGX) has released an update.
Jaguar Health, Inc. is on the brink of being delisted from the Nasdaq as its stock price has failed to meet the minimum $1.00 requirement for an extended period. Despite receiving grace periods to rectify the issue, the company’s stock has continued to plummet, currently trading at $0.10 or less. The company faces delisting effective February 26, 2024, but has the chance to appeal before then. Amidst this precarious situation, Jaguar Health is considering all available options to regain compliance and maintain its listing, but there is no guarantee of success.
For further insights into JAGX stock, check out TipRanks’ Stock Analysis page.
